| COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection H Al-Samkari, RS Karp Leaf, WH Dzik, JCT Carlson, AE Fogerty, ... Blood, The Journal of the American Society of Hematology 136 (4), 489-500, 2020 | 1357 | 2020 |
| Hemophagocytic lymphohistiocytosis H Al-Samkari, N Berliner Annual review of pathology: mechanisms of disease 13, 27-49, 2018 | 396 | 2018 |
| Second international guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia ME Faughnan, JJ Mager, SW Hetts, VA Palda, K Lang-Robertson, ... Annals of internal medicine 173 (12), 989-1001, 2020 | 320 | 2020 |
| Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist’s perspective A Kritharis, H Al-Samkari, DJ Kuter Haematologica 103 (9), 1433, 2018 | 172 | 2018 |
| The many roles of tranexamic acid: an overview of the clinical indications for TXA in medical and surgical patients J Cai, J Ribkoff, S Olson, V Raghunathan, H Al‐Samkari, TG DeLoughery, ... European journal of haematology 104 (2), 79-87, 2020 | 168 | 2020 |
| Thrombosis, bleeding, and the observational effect of early therapeutic anticoagulation on survival in critically ill patients with COVID-19 H Al-Samkari, S Gupta, RK Leaf, W Wang, RP Rosovsky, SK Brenner, ... Annals of internal medicine 174 (5), 622-632, 2021 | 125 | 2021 |
| Effects and interferences of emicizumab, a humanised bispecific antibody mimicking activated factor VIII cofactor function, on coagulation assays JI Adamkewicz, DC Chen, I Paz-Priel Thrombosis and haemostasis 119 (07), 1084-1093, 2019 | 120 | 2019 |
| ABO phenotype and death in critically ill patients with COVID‐19 RK Leaf, H Al‐Samkari, SK Brenner, S Gupta, DE Leaf British journal of haematology 190 (4), e204, 2020 | 103 | 2020 |
| Therapeutic advances in COVID-19 N Murakami, R Hayden, T Hills, H Al-Samkari, J Casey, L Del Sorbo, ... Nature Reviews Nephrology 19 (1), 38-52, 2023 | 100 | 2023 |
| Perioperative thrombocytopenia: evidence, evaluation, and emerging therapies A Nagrebetsky, H Al-Samkari, NM Davis, DJ Kuter, JP Wiener-Kronish British Journal of Anaesthesia 122 (1), 19-31, 2019 | 94 | 2019 |
| An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT-Bleed study H Al-Samkari, RS Kasthuri, JG Parambil, HA Albitar, YA Almodallal, ... Haematologica 106 (8), 2161, 2021 | 83 | 2021 |
| Laboratory monitoring in emicizumab-treated persons with hemophilia A J Müller, I Pekrul, B Pötzsch, B Berning, J Oldenburg, M Spannagl Thrombosis and Haemostasis 119 (09), 1384-1393, 2019 | 83 | 2019 |
| Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancy H Al-Samkari, JM Connors Hematology 2014, the American Society of Hematology Education Program Book …, 2019 | 79 | 2019 |
| Optimal use of thrombopoietin receptor agonists in immune thrombocytopenia H Al-Samkari, DJ Kuter Therapeutic advances in hematology 10, 2040620719841735, 2019 | 78 | 2019 |
| A modern reassessment of glycoprotein-specific direct platelet autoantibody testing in immune thrombocytopenia H Al-Samkari, RP Rosovsky, RS Karp Leaf, DB Smith, K Goodarzi, ... Blood Advances 4 (1), 9-18, 2020 | 77 | 2020 |
| Thrombopoietin level predicts response to treatment with eltrombopag and romiplostim in immune thrombocytopenia H Al‐Samkari, DJ Kuter American Journal of Hematology 93 (12), 1501-1508, 2018 | 70 | 2018 |
| Immune thrombocytopenia in adults: modern approaches to diagnosis and treatment H Al-Samkari, DJ Kuter Seminars in thrombosis and hemostasis 46 (03), 275-288, 2020 | 69 | 2020 |
| A multicenter study of romiplostim for chemotherapy-induced thrombocytopenia in solid tumor s and hematologic malignancies H Al-Samkari, AD Parnes, K Goodarzi, JI Weitzman, JM Connors, ... Haematologica 106 (4), 1148, 2021 | 59 | 2021 |
| Hereditary hemorrhagic telangiectasia: systemic therapies, guidelines, and an evolving standard of care H Al-Samkari Blood, The Journal of the American Society of Hematology 137 (7), 888-895, 2021 | 59 | 2021 |
| Systemic bevacizumab for the treatment of chronic bleeding in hereditary haemorrhagic telangiectasia H Al‐Samkari, A Kritharis, JM Rodriguez‐Lopez, DJ Kuter Journal of internal medicine 285 (2), 223-231, 2019 | 58 | 2019 |
